[New clinical tests that physicians should know for diagnosis of hematologic diseases].
Maruyama
I
I
D017153:Antibodies, Anticardiolipin / Q000097:blood; D000990:Antithrombin III / Q000032:analysis; D015415:Biomarkers / Q000097:blood; D005338:Fibrin Fibrinogen Degradation Products / Q000032:analysis; D005344:Fibrinopeptide A / Q000032:analysis; D006402:Hematologic Diseases / Q000175:diagnosis*; D006710:Homocysteine / Q000097:blood; D006801:Humans; D010446:Peptide Fragments / Q000032:analysis; D010447:Peptide Hydrolases / Q000032:analysis; D017395:Plasminogen Activator Inhibitor 1 / Q000032:analysis; D011516:Prothrombin / Q000032:analysis; D018180:Thrombomodulin / Q000097:blood
D017153:Antibodies, Anticardiolipin; D015415:Biomarkers; D005338:Fibrin Fibrinogen Degradation Products; D010446:Peptide Fragments; D017395:Plasminogen Activator Inhibitor 1; D018180:Thrombomodulin; C046193:antithrombin III-protease complex; C011468:fibrinmonomer; C045879:prothrombin fragment 1.2; D006710:Homocysteine; D005344:Fibrinopeptide A; D000990:Antithrombin III; D011516:Prothrombin; D010447:Peptide Hydrolases